Systematic review of pleural-amniotic shunt insertion vs. conservative management in isolated bilateral fetal hydrothorax without hydrops
- 82 Downloads
Abstract
Objective
In the management of bilateral fetal hydrothorax where the fetus is non-hydropic and apparently otherwise normal, we wished to determine if pleural-amniotic shunt insertion was better than conservative management in terms of mortality.
Methods
A systematic review was conducted between 1992 and 2017. Data extracted was inspected for heterogeneity. Where there was comparative data available, the odds ratio (OR) and confidence interval (CI) were calculated.
Results
Seven studies were included in this systematic review. There was a paucity of comparative data where only 2 studies (28 cases) allowed for direct comparison. Within the limitations of the study, there was no difference between shunt insertion vs. conservative management in terms of stillbirth or miscarriage (OR = 1.00, 95% CI 0.12–8.34, heterogeneity I2 = 0%, p = 1.00).
Conclusion
There is insufficient data available to determine whether the outcome is improved by pleural-amniotic shunt insertion compared with conservative management in cases of bilateral fetal hydrothorax where the fetus is non-hydropic and otherwise normal.
Keywords
Fetal therapy Hydrothorax Pleural effusion Shunt Thoracoamniotic shuntingIntroduction
In a pregnancy complicated by a fetus with primary bilateral hydrothorax with no other identifiable anomaly, the decision for pleural-amniotic shunt insertion or conservative management can be a therapeutic dilemma. Most clinicians faced with this clinical situation would consider shunt insertion in the presence of hydrops on the grounds that conservative management would likely result in fetal demise. If, however, the fetus was not hydropic, many clinicians would adopt a conservative approach while others would offer shunt insertion.
Given that pleural-amniotic shunt insertion is not without risk, with a procedure-related loss rate of about 1%, this question merits investigation. In this paper, we propose to study pregnancy where the fetus has primary bilateral hydrothorax with no other anomaly and is not hydropic. We wished to perform a systematic review of shunt insertion vs. conservative management in these cases.
Materials and methods
This systematic review was based on a protocol developed using widely recommended methods for the systematic review of observational studies [10, 12, 21, 23; Henderson et al. 2009]. The study was registered with the PROSPERO database (registration number CRD42017060485; www.crd.york.ac.uk/PROSPERO).
Search strategy
The search strategy involved searching the bibliographic databases MEDLINE and EMBASE, the Cochrane library and Web of Science between March 1992 and March 2017 inclusive, and followed the PRISMA guidelines [14]. The search terms used were “fetus, fetal, foetus, and foetal in combination with hydrothorax, chylothorax, pleural effusion, thoracoamniotic shunt, and shunting. A combination of MeSH and text words was used. All relevant abstracts were reviewed and where the abstract met the pre-defined selection criteria, the full article was retrieved and reviewed. No language restriction was applied. Experts in the area were consulted to ensure the review encompassed all relevant papers.
Study selection
Population—Pregnancies with non-hydropic fetuses with primary bilateral fetal hydrothorax managed with thoracoamniotic shunting or conservative management.
Outcome—intrauterine demise (stillbirth or miscarriage), neonatal death.
Study design—Prospective and retrospective studies including case series involving more than 5 cases.
Quality assessment and data extraction
Data collection—Prospective data was considered ideal; retrospective collection was considered second best.
Description of population—A well-defined sample at a uniform early stage with clear documentation of gestation at diagnosis, gestation at intervention, and delivery was considered ideal.
Prognostic factors considered: Clear documentation of other anomalies was considered ideal.
Objective outcome—Clear documentation of intrauterine demise or neonatal death was considered ideal.
Outcome ascertainment—Greater than 90% follow-up of the original study population was considered ideal, less than 90% was considered second best.
Data synthesis
The extracted data were tabulated to allow qualitative inspection for clinical and methodological heterogeneity. The data were not weighted according to the quality of the paper. For comparison of dichotomous outcomes between groups, the odds ratio (OR) and standard errors were calculated for the association in each study. The heterogeneity of estimates was explored graphically using forest plots and formally tested using χ2 tests. A combined proportion was calculated using the random effects models on the log odds scale. Data from individual studies were pooled [6]. The analysis of odds ratios was conducted using Review Manger 5 [1].
Results
Identification of the literature
Prisma flow diagram demonstrating study selection
Clinical details of the 7 studies included in the systematic review
Study | Number of patients | Number of non-hydropic fetuses with normal karyotype | Number underwent shunting | Average gestation at shunting | Average gestation at delivery | Antenatal care protocolized | Outcome survival | Duration of follow-up | Complications |
---|---|---|---|---|---|---|---|---|---|
Bianchi [4] | 28 | 12 | 28 | 28.5 | 36.2 | Yes | 22/28 | > 5 weeks | Respiratory distress syndrome, infection, mechanical ventilation, cerebral palsy, postnatal pleurodesis |
Estroff [9] | 11 | 10 | 0 | NA | Not reported | No | 7/10 | 3 years | Respiratory distress syndrome, chest drain |
Ba-Da Jeong [11] | 68 | 15 | 65 | 28.3 | Not reported | Yes | 14/15 | 0.3–183 months | Pulmonary hypoplasia, preterm labor, premature rupture of membranes, hydrops, pulmonary hypertension, pulmonary hemorrhage, disseminated intravascular coagulopathy, recurrent pneumonia, restrictive lung disease, asthma |
Derderian [7] | 17 | 7 | 1 | 25 | 37 | No | 0/1 | Not reported | Postnatal fluid drainage, shunt dislodgement, preterm labor |
Pellegrinelli [16] | 41 | 16 | 7 | 27 | Not reported | Not reported | 6/7 | Not reported | Premature rupture of membranes, mirror syndrome, disseminated intravascular coagulopathy from bleeding trocar site |
Takahashi | 24 | 7 | 7 | 27.4 | 34.8 | Yes | 7/7 | 28 days | PPROM, catheter displacement, mirror syn, polyhydramnios |
Smith | 92 | 5 | 5 | 24 | 33.6 | Yes | 3/5 | Range 8 weeks–2 years | Chest drain, removal of stuck shunt |
Study characteristics and quality
Quality assessment of studies in the systematic review using clinically important criteria
Quality assessment of studies in the systematic review (STROBE criteria)
Survival rates following shunt insertion vs. conservative management
Comparison of shunt insertion versus conservative management. Meta-analysis of the outcomes of stillbirth or miscarriage
There was a paucity of comparative data where only 2 studies (28 cases) allowed for direct comparison. Within the limitations of the study, there was no difference between shunt insertion vs. conservative management in terms of stillbirth or miscarriage (OR = 1.00, 95% CI 0.12–8.34, heterogeneity I2 = 0%, p = 1.00).
Discussion
This systematic review did not provide sufficient evidence for or against pleural-amniotic shunting in cases of bilateral hydrothorax where the fetus is non-hydropic and apparently otherwise normal. The number of cases was too small to reach a meaningful conclusion.
The strength of this review is that it employed an exhaustive research strategy. This way, we were able to collate evidence for a condition that is imprecisely assessed in individual studies. In addition, the quality of these studies was assessed.
A major weakness of this systematic review is that all the papers evaluated were retrospective in nature and the overall number of cases was very small.
A further weakness of this review is that subtle reasons whereby decision-making may change are not accounted for. For example, a clinician may see a woman with a non-hydropic fetus with bilateral hydrothorax at 20 weeks. He may decide to adopt a conservative approach as the fetus is in a difficult position for shunt insertion. By 24 weeks, the clinical picture may be the same but the fetus could be in a better position for shunt insertion. The clinician may well decide to opt for shunt insertion. Our systematic review would have classified such a case as an intervention. In reality, a period of conservative management followed by shunt insertion took place.
In the original conception of this systematic review, we hoped to study outcome at different gestations, i.e., 20 to 24 weeks, 24 to 28 weeks, 28 to 32 weeks, and 32 to 34 weeks. We were particularly keen to study the outcome at the later gestations, where iatrogenic premature delivery (with its attendant risk of morbidity and mortality) is a possibility. Due to the paucity of our data, we were not able to provide useful information at different gestations.
Conclusion
In cases of bilateral fetal hydrothorax, where the fetus is non-hydropic and otherwise structurally normal, the correct management strategy in terms of pleural-amniotic shunting or conservative management remains unknown.
A multicenter randomized controlled trial is the best way to answer this question but may prove to be an impossible undertaking. Another solution would be for several large units to standardize reporting at the outset and pool their respective results in a large observational study.
Summary
In a pregnancy complicated by a fetus with primary hydrothorax and no other identifiable anomaly, we wished to determine whether pleural-amniotic shunt insertion was better than conservative management in terms of mortality. To do this, we conducted a systematic review between 1992 and 2017 and identified seven studies from which we could extract data. There was a paucity of comparative data with only two studies allowing for direct comparison. Within the limitations of the review, there was no difference between shunt insertion vs. conservative management.
Notes
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
References
- 1.(2008) Review Manager (RevMan) 5th edn. The Nordic Cochrane Centre, The Cochrane Collaboration, CopenhagenGoogle Scholar
- 2.(2009) NHS Centre for Reviews and Dissemination CRD’s guidance for undertaking reviews in health care. In: York UO (ed). YorkGoogle Scholar
- 3.Bernaschek G, Deutinger J, Hansmann M, Bald R, Holzgreve W, Bollmann R (1994) Feto-amniotic shunting--report of the experience of four European centres. Prenat Diagn 14:821–833CrossRefPubMedGoogle Scholar
- 4.Bianchi S, Lista G, Castoldi F, Rustico M (2010) Congenital primary hydrothorax: effect of thoracoamniotic shunting on neonatal clinical outcome. J Matern Fetal Neonatal Med 23:1225–1229CrossRefPubMedGoogle Scholar
- 5.Blaicher W, Hausler M, Gembruch U, Bollmann R, Terinde R, Rempen A, Deutinger J, Bernaschek G (2005) Feto-amniotic shunting -- experience of six centres. Ultraschall Med 26:134–141CrossRefPubMedGoogle Scholar
- 6.Deeks JJ, Altman DG, Bradburn MJ (2001) Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. BMJ Books, LondonCrossRefGoogle Scholar
- 7.Derderian SC, Trivedi S, Farrell J, Keller RL, Rand L, Goldstein R, Feldstein VA, Hirose S, Mackenzie TC (2014) Outcomes of fetal intervention for primary hydrothorax. J Pediatr Surg 49:900–903 discussion 903-4CrossRefPubMedGoogle Scholar
- 8.Deurloo KL, Devlieger R, Lopriore E, Klumper FJ, Oepkes D (2007) Isolated fetal hydrothorax with hydrops: a systematic review of prenatal treatment options. Prenat Diagn 27:893–899CrossRefPubMedGoogle Scholar
- 9.Estoff JA, Parad RB, Frigoletto FD Jr, Benacerraf BR (1992) The natural history of isolated fetal hydrothorax. Ultrasound Obstet Gynecol 2:162–165CrossRefPubMedGoogle Scholar
- 10.Henderson LK, Craig JC, Willis NS, Tovey D, Webster AC (2010) How to write a Cochrane systematic review. Nephrology (Carlton) 15:617–624CrossRefGoogle Scholar
- 11.Jeong BD, Won HS, Lee MY, Shim JY, Lee PR, Kim A (2015) Perinatal outcomes of fetal pleural effusion following thoracoamniotic shunting. Prenat Diagn 35:1365–1370CrossRefPubMedGoogle Scholar
- 12.Khan K, Riet GT, Glanville J, Sowden A, Kleijnen J (2000) Undertaking systematic reviews of research on effectiveness. CRD’s guidance for carrying out or commissioning reviews, 2nd edn. NHS Centre for Reviews and Dissemination, University of York, YorkGoogle Scholar
- 13.Mallmann MR, Geipel A, Bludau M, Matil K, Gottschalk I, Hoopmann M, Muller A, Bachour H, Heydweiller A, Gembruch U, Berg C (2014) Bronchopulmonary sequestration with massive pleural effusion: pleuroamniotic shunting vs intrafetal vascular laser ablation. Ultrasound Obstet Gynecol 44:441–446CrossRefPubMedGoogle Scholar
- 14.Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 62:1006–1012CrossRefGoogle Scholar
- 15.O’brien B, Kesby G, Ogle R, Rieger I, Hyett JA (2015) Treatment of primary fetal hydrothorax with OK-432 (Picibanil): outcome in 14 fetuses and a review of the literature. Fetal Diagn Ther 37:259–266CrossRefPubMedGoogle Scholar
- 16.Pellegrinelli JM, Kohler A, Kohler M, Weingertner AS, Favre R (2012) Prenatal management and thoracoamniotic shunting in primary fetal pleural effusions: a single centre experience. Prenat Diagn 32:467–471CrossRefPubMedGoogle Scholar
- 17.Petersen S, Kaur R, Thomas JT, Cincotta R, Gardener G (2013) The outcome of isolated primary fetal hydrothorax: a 10-year review from a tertiary center. Fetal Diagn Ther 34:69–76CrossRefPubMedGoogle Scholar
- 18.Rennie D (2003) Improving reports of studies of diagnostic tests: the STARD initiative. JAMA 289:89–90CrossRefPubMedGoogle Scholar
- 19.Rustico MA, Lanna M, Coviello D, Smoleniec J, Nicolini U (2007) Fetal pleural effusion. Prenat Diagn 27:793–799CrossRefPubMedGoogle Scholar
- 20.Smith RP, Illanes S, Denbow ML, Soothill PW (2005) Outcome of fetal pleural effusions treated by thoracoamniotic shunting. Ultrasound Obstet Gynecol 26:63–66CrossRefPubMedGoogle Scholar
- 21.Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283:2008–2012Google Scholar
- 22.Takahashi Y, Kawabata I, Sumie M, Nakata M, Ishii K, Murakoshi T, Katsuragi S, Ikeda T, Saito M, Kawamoto H, Hayashi S, Sago H (2012) Thoracoamniotic shunting for fetal pleural effusions using a double-basket shunt. Prenat Diagn 32:1282–1287CrossRefPubMedGoogle Scholar
- 23.von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med 4:e296CrossRefGoogle Scholar
- 24.Yinon Y, Kelly E, Ryan G (2008) Fetal pleural effusions. Best Pract Res Clin Obstet Gynaecol 22:77–96CrossRefPubMedGoogle Scholar
Copyright information
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.